Zoetis Inc. (ZTS) Stock Overview
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
About Zoetis Inc.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company…
Source: Yahoo Finance
Sector & Industry
Zoetis Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NYSE exchange.
Zoetis Inc. at a Glance
| Company | Zoetis Inc. |
| Ticker | ZTS |
| Exchange | NYSE |
| Currency | USD |
| Price | $76.56 |
| Market cap | $32.10B |
| P/E ratio (trailing) | 12.55 |
| EPS (trailing) | $6.10 |
| 52-week high | $160.48 |
| 52-week low | $71.47 |
| Dividend yield | 2.77% |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 14,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Zoetis Inc.'s P/E ratio?
Zoetis Inc. (ZTS) has a trailing P/E ratio of 12.55 as of our latest data snapshot.
What is Zoetis Inc.'s market cap?
Zoetis Inc.'s market capitalisation is $32.10B based on the most recent snapshot.
What is ZTS's 52-week range?
Over the past 52 weeks, ZTS has traded between $71.47 and $160.48.
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: